Clinical Trials Directory

Trials / Unknown

UnknownNCT04188158

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
238 (estimated)
Sponsor
Universidad de León · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Effectiveness analysis of neoadjuvant chemotherapy in the treatment of locally advanced colon cancer. ELECLA trial

Detailed description

Participants in this study selected patients according to homogeneous inclusion criteria and will be treated either with a uniform protocol of neoadjuvant chemotherapy, surgery and complementary chemotherapy (intervention group), or with the standard scheme of postoperative surgery and chemotherapy (control group ). All patients will be studied basally through clinical examinations and radiological and endoscopic tests usually used to reach the diagnosis of Locally Advanced Colon Cancer . In the group of patients receiving neoadjuvant treatment, the CT scan will be repeated after the completion of preoperative chemotherapy to restage the disease and quantify the degree of tumor response. Finally, the project tries to determine whether the neoadjuvant treatment scheme increases disease-free survival (SLE) at 2 and 5 years and overall survival (OS) at 5 years. Likewise, the toxicity derived from chemotherapy treatment and perioperative morbidity and mortality will be analyzed to evaluate the feasibility and safety of the therapeutic procedure. The rate of completion of chemotherapy in both groups will also be compared.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTCAPECITABINE AND OXALIPLATINIntervention Group: Neoadjuvant chemotherapy ( 3 cycles Capecitabine and oxaliplatin) + surgery + adjuvant chemotherapy (5 cycles Capecitabine and oxaliplatin)

Timeline

Start date
2017-03-10
Primary completion
2023-05-10
Completion
2024-03-10
First posted
2019-12-05
Last updated
2019-12-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04188158. Inclusion in this directory is not an endorsement.